Eléments de l'association

	Suresh Ramalingam	1
	EGFR tyrosine kinase inhibitor	1
	Suresh Ramalingam *Sauf* EGFR tyrosine kinase inhibitor"	0
	EGFR tyrosine kinase inhibitor *Sauf* Suresh Ramalingam"	0
	Suresh Ramalingam Et EGFR tyrosine kinase inhibitor	1
	Suresh Ramalingam Ou EGFR tyrosine kinase inhibitor	1
	*Corpus*	921

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000812	Cindy L. O'Bryant [États-Unis] ; Paul Haluska [États-Unis] ; Lee Rosen [États-Unis] ; Ramesh K. Ramanathan [États-Unis] ; Balaji Venugopal [Royaume-Uni] ; Stephen Leong [États-Unis] ; Ramesh Boinpally [États-Unis] ; Amy Franke [États-Unis] ; Karsten Witt [États-Unis] ; Jeffry Evans [Royaume-Uni] ; Chandra Belani [États-Unis] ; S. Gail Eckhardt [États-Unis] ; Suresh Ramalingam [États-Unis]	An open-label study to describe pharmacokinetic parameters of erlotinib in patients with advanced solid tumors with adequate and moderately impaired hepatic function

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021